JACK W SCHULER
CIK 1021412 · Chairman · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$163.70M
Companies
20
Total Filings
409
Lifetime Open-Market Net
$216.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDSX | Director | 1,563,210 | $15.06 | $23.54M | $50.92M | 45 | 2026-01-27 |
| Aspira Women's Health Inc. (AWH) Delisted | 10%+ Owner | 1,918,692 | $0.08 | $157.3K | $8.50M | 6 | 2025-03-10 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 25,722 | $0.03 | $875 | $137.68M | 186 | 2024-12-03 |
| YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | 10%+ Owner | 1,566,956 | $0.35 | $548.6K | $8.88M | 13 | 2023-12-20 |
| SLNO | 10%+ Owner | 46,595 | $53.01 | $2.47M | $13.02M | 9 | 2023-05-15 |
| Aspira Women's Health Inc. (VRML) Delisted | 10%+ Owner | 29,781,831 | — | — | $11.71M | 15 | 2020-06-11 |
| QDEL | Director | 6,517,302 | $14.13 | $92.09M | $8.04M | 34 | 2020-05-18 |
| BIOLASE, INC (BIOL) Delisted | 10%+ Owner | 739,820 | $0.02 | $12.9K | $2.31M | 8 | 2020-05-15 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | 10%+ Owner | 4,550,678 | — | — | $4.87M | 1 | 2018-12-26 |
| STERICYCLE INC (SRCLP) Delisted | Director | 655,482 | — | — | $625.9K | 7 | 2018-05-02 |
| STERICYCLE INC (SRCL) Delisted | Director | 700,528 | $61.98 | $43.42M | -$71.69M | 29 | 2016-05-27 |
| STERICYCLE INC (SRCL.P) Delisted | Director | 654,738 | — | — | $0 | 1 | 2015-12-23 |
| Neos Therapeutics, Inc. (NEOS) Delisted | 10%+ Owner | 1,541,149 | $1.15 | $1.77M | $300.0K | 1 | 2015-07-28 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | 10%+ Owner | 2,185,652 | — | — | $5.53M | 1 | 2015-06-23 |
| HANSEN MEDICAL INC (HNSN) Delisted | Director | 18,553,409 | — | — | $0 | 3 | 2015-06-15 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Director | 6,940,892 | — | — | $12.21M | 8 | 2014-03-21 |
| MDT | Director | 568,617 | $80.20 | $45.60M | $21.27M | 31 | 2013-06-27 |
| Transition Therapeutics Inc. (TTHI) Delisted | 10%+ Owner | 2,823,010 | — | — | $2.60M | 1 | 2011-11-23 |
| VENTANA MEDICAL SYSTEMS INC (VMSI) Delisted | Director | 0 | — | — | $0 | 5 | 2008-02-20 |
| ICOS CORP (ICOS) Delisted | Director | 0 | — | — | $0 | 1 | 2007-01-30 |
Recent Filings · Page 4 of 41
409 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-25 | Aspira Women's Health Inc. (AWH) Delisted | Buy (P) | +181,800 | $499.9K | EDGAR |
| 2023-06-29 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | +39,199,211 | $40.38M | EDGAR |
| 2023-06-01 | Accelerate Diagnostics, Inc (AXDX) Delisted | Exer (M) | +75,949 | $0 | EDGAR |
| 2023-06-01 | BDSX | Buy (P) | +26,641 | $36.2K | EDGAR |
| 2023-06-01 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | BDSX | Buy (P) | +52,508 | $71.3K | EDGAR |
| 2023-05-26 | BDSX | Buy (P) | +35,308 | $44.0K | EDGAR |
| 2023-05-25 | BDSX | Buy (P) | +56,782 | $65.1K | EDGAR |
| 2023-05-25 | BDSX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.